Literature DB >> 23978498

Corticosteroid responsive prolonged thrombocytopenia in a case of dengue fever.

Shailendra Prasad Verma1, Abdoul Hamide, Jyoti Wadhwa, Kalaimani Sivamani.   

Abstract

Thrombocytopenia and bleeding manifestations are consistent features of dengue fever. Usually thrombocytopenia resolves and platelet count normalises by day 10 of fever. Persistent thrombocytopenia is not a feature of dengue fever. Proposed mechanisms behind thrombocytopenia are many. Direct platelet destruction by dengue virus, immune-mediated platelet destruction and even megakaryocytic immune injury have been proposed as underlying mechanisms. We are reporting a case of an old man who presented in dengue season in 2012 with fever and bleeding and was diagnosed as a case of dengue fever. He developed persistent thrombocytopenia requiring treatment on the lines of immune thrombocytopenia and responded to steroids. Other causes of thrombocytopenia were ruled out.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23978498      PMCID: PMC3762371          DOI: 10.1136/bcr-2013-200249

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis.

Authors:  A K Falconar
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

2.  Antibody-enhanced binding of dengue-2 virus to human platelets.

Authors:  S Wang; R He; J Patarapotikul; B L Innis; R Anderson
Journal:  Virology       Date:  1995-10-20       Impact factor: 3.616

3.  Corticosteroid-responsive prolonged thrombocytopenia following dengue haemorrhagic fever.

Authors:  K W Leong; P Srinivas
Journal:  Med J Malaysia       Date:  1993-09

4.  [Hematological aspects of dengue fever].

Authors:  S F Lin; H W Liu; C S Chang; J H Yen; T P Chen
Journal:  Gaoxiong Yi Xue Ke Xue Za Zhi       Date:  1989-01

5.  Generation of IgM anti-platelet autoantibody in dengue patients.

Authors:  C F Lin; H Y Lei; C C Liu; H S Liu; T M Yeh; S T Wang; T I Yang; F C Sheu; C F Kuo; Y S Lin
Journal:  J Med Virol       Date:  2001-02       Impact factor: 2.327

Review 6.  Hemostatic defects in dengue hemorrhagic fever.

Authors:  N Bhamarapravati
Journal:  Rev Infect Dis       Date:  1989 May-Jun

7.  Alterations in thrombopoiesis in patients with thrombocytopenia produced by dengue hemorrhagic fever.

Authors:  E Putintseva; G Vega; L Fernández
Journal:  Nouv Rev Fr Hematol       Date:  1986

Review 8.  Mechanisms of dengue virus-induced bone marrow suppression.

Authors:  V F La Russa; B L Innis
Journal:  Baillieres Clin Haematol       Date:  1995-03

9.  Steroid responsive prolonged thrombocytopenia in dengue.

Authors:  Ashish Bhalla; R Bagga; L K Dhaliwal; R Sharma; S Varma
Journal:  Indian J Med Sci       Date:  2010-02
  9 in total
  2 in total

1.  Dengue and HELLP: Beware of the Masquerade.

Authors:  Rohit Patnaik; Shruthi Kulkarni; Nupur Karan
Journal:  Indian J Crit Care Med       Date:  2022-05

Review 2.  Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment.

Authors:  Victor C Gan
Journal:  Curr Treat Options Infect Dis       Date:  2014
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.